Crossmark

Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro

Crossref DOI link: https://doi.org/10.1007/s11481-017-9755-4

Published Online: 2017-07-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Peipei

Wang, Yingchun

Qin, Zhao

Qiu, Lisha

Zhang, Min

Huang, Yunlong

Zheng, Jialin C. https://orcid.org/0000-0002-6269-2984
Funding

Funding for this research was provided by:

Ministry of Science and Technology of the People's Republic of China (2014CB965000, 2014CB965001, 2014CB965003)

National Natural Science Foundation of China (81221001)

National Natural Science Foundation of China (81329002)

National Institutes of Health (2R56NS041858-15A1)

National Institutes of Health (1R01NS097195-01)

National Institutes of Health (R03NS094071-01)
License Information

Text and Data Mining valid from 2017-07-22

Version of Record valid from 2017-07-22
More Information

Article History

Received: 14 April 2017

Accepted: 7 July 2017

First Online: 22 July 2017

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below